Drug Shortage Report for KIVEXA
| Report ID | 74011 |
| Drug Identification Number | 02269341 |
| Brand name | KIVEXA |
| Common or Proper name | abacavir (as abacavir sulfate) and lamivudine tablets |
| Company Name | VIIV HEALTHCARE ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ABACAVIR LAMIVUDINE |
| Strength(s) | 600MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30's |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-25 |
| Estimated end date | 2019-03-18 |
| Actual end date | 2019-03-14 |
| Shortage status | Resolved |
| Updated date | 2019-03-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-877-393-8448 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-03-15 | English | Compare |
| v6 | 2019-03-14 | French | Compare |
| v5 | 2019-03-14 | English | Compare |
| v4 | 2019-02-27 | French | Compare |
| v3 | 2019-02-27 | English | Compare |
| v2 | 2019-01-30 | French | Compare |
| v1 | 2019-01-30 | English | Compare |
Showing 1 to 7 of 7